-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PXhup/ZoK/sXK35LXo3099Z9G2p/R9GOZellAgCHIIg+EV61Syk7zdW5IQTYy82Q pd4c6WH+7uyro1BPc0d50Q== 0000898430-99-000986.txt : 19990318 0000898430-99-000986.hdr.sgml : 19990318 ACCESSION NUMBER: 0000898430-99-000986 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 19990317 EFFECTIVENESS DATE: 19990317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: SEC FILE NUMBER: 333-74585 FILM NUMBER: 99567325 BUSINESS ADDRESS: STREET 1: 1840 DEHAVILLAND DR CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1789 BUSINESS PHONE: 0854471000 MAIL ADDRESS: STREET 1: 1840 DEHAVILLAND DR. STREET 2: MAIL STOP 10-1-B-512 CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1789 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 S-8 1 FORM S-8 As filed with the Securities and Exchange Commission on March 17, 1999 Registration No. 333- - -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AMGEN INC. (Exact name of registrant as specified in its charter) DELAWARE 95-3540776 (State or other jurisdiction (I.R.S. Employer of incorporation or organization) Identification No.) One Amgen Center Drive Thousand Oaks, California 91320-1789 (Address of Principal Executive Offices) (Zip Code) ---------------- AMGEN LIMITED SHARESAVE PLAN (Full title of the plan) ------------------ GEORGE A. VANDEMAN, ESQ. Senior Vice President, Corporate Development, General Counsel and Secretary Amgen Inc. One Amgen Center Drive Thousand Oaks, California 91320-1799 (Name and address of agent for service) (805) 447-1000 (Telephone Number, Including Area Code, of Agent For Service) ------------------- Copies to: GARY OLSON, ESQ. Latham & Watkins 633 West Fifth Street, Suite 4000 Los Angeles, California 90071-2007 (213) 485-1234 CALCULATION OF REGISTRATION FEE - --------------------------------------------------------------------------------
Proposed Proposed Title of Amount Maximum Maximum Securities to be to be Offering Price Aggregate Amount of Registered Registered Per Share (1) Offering Price (1) Registration Fee - --------------------------------------------------------------------------------------------------- Common Stock 200,000 $48.90 $9,780,000 $2,718.84 $.0001 par value ===================================================================================================
_________________________ (1) For purposes of computing the registration fee only. Pursuant to Rule 457(h), the Proposed Maximum Offering Price Per Share is based upon the basis of the price at which the options may be exercised by the employees of Amgen Limited, a wholly-owned subsidiary of Amgen Inc. Exhibit Index appears on Page 7 PART I Item 1. Plan Information Not required to be filed with this Registration Statement. Item 2. Registrant Information and Employee Plan Annual Information Not required to be filed with this Registration Statement. PART II Item 3. Incorporation of Documents by Reference The registrant, Amgen Inc., a Delaware corporation (the "Company" or the "Registrant"), hereby incorporates the following documents in this Registration Statement by reference: A. The Company's Annual Report on Form 10-K for the year ended December 31, 1998; and B. Description of the Company's Common Stock, Contractual contingent payment rights and preferred share rights plan contained in the Registration Statements on Form 8-A filed with the SEC on September 7, 1983 and April 1, 1993, and the Form 8-K filed with the SEC on February 28, 1997, respectively. All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, are incorporated by reference in this Registration Statement and are a part hereof from the date of filing such documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement. Item 4. Description of Securities Not applicable. Item 5. Interests of Named Experts and Counsel Not applicable. Item 6. Indemnification of Directors and Officers Section 145 of the Delaware General Corporation Law, the Restated Certificate of Incorporation, as amended, and the Amended and Restated Bylaws of the Company contain provisions covering indemnification of corporate directors and officers against certain liabilities and expenses incurred as a result of proceedings involving such persons in their capacities as directors and officers, including proceedings under the Securities Act of 1933, as amended (the "Securities Act") and the Exchange Act. The Company has authorized the entering into of indemnity contracts and provides indemnity insurance pursuant to which officers and directors are indemnified or insured against liability or loss under certain circumstances which may include liability or related loss under the Securities Act and the Exchange Act. Item 7. Exemption from Registration Claimed Not applicable. 2 Item 8. Exhibits 4.1 Amgen Limited Sharesave Plan 5.1 Opinion of Latham & Watkins as to the legality of the shares being registered. 23.1 Consent of Ernst & Young LLP 23.2 Consent of Latham & Watkins (included in Exhibit 5.1 hereto). 24.1 Powers of Attorney (included on page 5). Item 9. Undertakings The undersigned registrant hereby undertakes: (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement: (a) To include any prospectus required by Section 10(a)(3) of the Securities Act; (b) To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission (the "Commission") pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement; (c) To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement; provided, however, that paragraphs (1)(a) and (1)(b) shall not apply if the registration statement is on Form S-3 or Form S-8 and the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement. (2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant 3 has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. 4 SIGNATURES Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Thousand Oaks, State of California, on this 17th day of March, 1999. AMGEN INC. By: /s/ Kathryn E. Falberg ----------------------------------------- Kathryn E. Falberg Senior Vice President, Finance, and Chief Financial Officer POWER OF ATTORNEY We, the undersigned officers and directors of Amgen Inc., and each of us, do hereby constitute and appoint each and any of Gordon M. Binder, Kevin W. Sharer, Kathryn E. Falberg and George A. Vandeman, our true and lawful attorney and agent, with full power of substitution and resubstitution, to do any and all acts and things in our name and behalf in any and all capacities and to execute any and all instruments for us in our names, in connection with this Registration Statement or any registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, including specifically, but without limitation, power and authority to sign for us or any of us in our names in the capacities indicated below, any and all amendments (including post-effective amendments) hereto; and we hereby ratify and confirm all that said attorney and agent, or his substitute, shall do or cause to be done by virtue thereof. Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated:
Signatures Title Date ---------- ----- ---- /s/ Gordon M. Binder Chairman of the Board and March 17, 1999 - ------------------------------------- Chief Executive Officer Gordon M. Binder Principal Executive Officer) /s/ Kevin W. Sharer President, Chief Operating March 17, 1999 - ------------------------------------- Officer and Director Kevin W. Sharer /s/ Kathryn E. Falberg Senior Vice President, March 17, 1999 - ------------------------------------- Finance, and Chief Financial Kathryn E. Falberg Officer (Principal Financial Officer) /s/ Marc M.P. de Garidel Vice President, Controller and March 17, 1999 - ------------------------------------- Chief Accounting Officer Marc M.P. de Garidel (Principal Accounting Officer) /s/ William K. Bowes, Jr. Director March 17, 1999 - ------------------------------------- William K. Bowes, Jr.
5
Signatures Title Date ---------- ----- ---- /s/ Jerry D. Choate Director March 17, 1999 - -------------------------------------- Jerry D. Choate /s/ Frederick W. Gluck Director March 17, 1999 - -------------------------------------- Frederick W. Gluck /s/ Franklin P. Johnson, Jr. Director March 17, 1999 - -------------------------------------- Franklin P. Johnson, Jr. /s/ Steven Lazarus Director March 17, 1999 - -------------------------------------- Steven Lazarus /s/ Gilbert S. Omenn Director March 17, 1999 - -------------------------------------- Gilbert S. Omenn /s/ Judith C. Pelham Director March 17, 1999 - -------------------------------------- Judith C. Pelham
6 EXHIBIT INDEX
Exhibit Number Description - ------- ----------- *4.1 Amgen Limited Sharesave Plan *5.1 Opinion of Latham & Watkins regarding the legality of the shares being registered *23.1 Consent of Ernst & Young LLP *23.2 Consent of Latham & Watkins (included in opinion filed as Exhibit 5.1) *24 Power of Attorney (included on signature page to Registration Statement)
_________________ *Filed herewith. 7 EX-4.1 2 AMGEN LIMITED SHARESAVE PLAN EXHIBIT 4.1 Rules of the Amgen Limited Sharesave Plan 1. Definitions In these Rules: 1.1 the following words and expressions have the following meanings: "Act" the Income and Corporation Taxes Act 1988; "Associated Company" an associated company of the Company within the meaning of Section 187(2) of the Act; "Auditors" the auditors nominated by the Directors for the purposes of the Plan; "Bonus Date" the date on which a bonus becomes payable under the relevant Savings Contract after payment of 36 Savings Contributions; "Business Day" any day on which Shares may be dealt in on the U.S. NASDAQ Stock Market National Market system (or such other system exchange on which the shares are then traded); "Company" Amgen Limited; "Contractual Savings Scheme" the arrangement specified for the time being by the Directors under which Savings Contributions are made by a Participant in accordance with the Plan, such arrangement being a certified contractual savings scheme within the meaning of Section 326 of the Act which has been approved by the Commissioners of Inland Revenue for the purposes of Schedule 9 to the Act; "Control" the meaning given to that expression in Section 840 of the Act; "Date of Exercise" the meaning given to that expression in Rule 5.2 "Date of Grant" the date on which the Directors grant an Option in accordance with the terms of Rule 2; "Date of Invitation" the date on which any notice is given pursuant to Rule 2.1; 1 "Directors" The board of directors for the time being of the Company or a duly appointed committee thereof; "Eligible Employee" any person (including a full-time director) who at any Date of Invitation is in the employment of any Participating Company and who has been in that employment for at least one day and who is then chargeable to tax in respect of such employment under Case I of Schedule E; or such other person in the employment of a Participating Company as the Directors may decide. For the purposes of this paragraph "full-time" shall mean having a normal contractual working week of 25 hours or more, excluding meal breaks; "Employment" employment with the Company and/or any company under the Control of the Company or any Associated Company or with any Jointly- owned Company and "ceasing to be in Employment" shall be construed as ceasing to be employed by all such companies; "Exchange Rate" the actual rate of exchange prevailing on conversion at the Date of Exercise of a Participant's payment for the exercise of an Option from Pounds Sterling to US Dollars; "Exercise Notice" the meaning given to that expression in Rule 4.3; "Group" the Company and all its Subsidiaries and Jointly-owned Companies; "Jointly-owned Company" (a) a company which is not under the Control of any single person; and (b) under the Control of two persons between them one of such persons being the Company; and (c) not a participating company in any other company's group scheme (as those terms are defined in paragraph 1 of Schedule 9 to the Act ) and any other company which is under the Control of a company which meets the conditions in paragraphs (a), (b) and (c) above and is not itself a participating company in any other company's group scheme (as those terms 2 are defined in paragraph 1 of Schedule 9 to the Act); "Minimum Savings Contribution" (Pounds)10 or such other amount specified by the Directors from time to time, which shall be no greater than the amount for the time being specified by paragraph 24(2)(b) of Schedule 9 to the Act and no lower than the minimum Savings Contribution permitted by the relevant Contractual Savings Scheme; "Option" the right granted or to be granted on any particular Date of Grant to acquire Shares in accordance with the Rules; "Option Certificate" a certificate evidencing an Option as referred to in Rule 2.6; "Option Price" the price in US Dollars for the acquisition of a Share comprised in any Option which shall be determined by the Directors and shall (subject to the provisions of Rules 6) be not less than an amount equal to 80 per cent of the market value of a Share determined in accordance with sections 272 and 273 of the Taxation of Chargeable Gains Act 1992 and agreed for the purposes of the Amgen Limited Sharesave Plan with the Shares Valuation Division of the Inland Revenue for the Business Day last preceding the relevant Date of Invitation; "Parent Company" Amgen Inc. incorporated in the state of Delaware in the United States of America; "Participant" any person (including, where the context permits, the legal personal representatives of such a person) who holds an Option; "Participating Company" the Company and any other company within the Group which the Directors have determined shall be a Participating Company for the purposes of the Plan provided that any Jointly-owned Company which ceases to be a Jointly-owned Company and which does not then become a Subsidiary shall cease to be a Participating Company; "Plan" this Plan, being the Amgen Limited Sharesave Plan as adopted by the Directors on [ , 1998] and as amended from time to time; 3 "Record Date" in relation to any particular payment of dividend or other right attaching to Shares the date on which the Parent company determines, in accordance with Delaware law, the Parent Company By-Laws and the Parent Company Certificate of Incorporation, a date to be the record date for holders of the shares; "Redundancy" redundancy within the meaning of the Employment Rights Act 1996; "Retirement" retirement on reaching age 60 or any other age at which a Participant is bound to retire in accordance with the terms of his contract of employment; "Rules" these rules together with any amendment thereto effected in accordance with Rule 7; "Savings Contract" a savings contract entered into under a Contractual Savings Scheme; "Savings Contract Repayment" in respect of a Savings Contract the amount in US Dollars at the Exchange Rate of the repayment of a person's Savings Contributions plus any bonus or, if the Option is exercised before the Bonus Date, any interest; "Savings Contribution" the amount payable per month by a Participant by way of contributions under a Savings Contract in respect of any Option which amount shall normally be paid by means of periodic deductions from the Participant's remuneration by his employer and shall be an integral multiple of (Pounds)1 and shall be not less than the Minimum Savings Contribution; "Share" a share in the common stock, par value $.0001 per share, of the Parent Company which complies with the provisions of paragraphs 10 to 14 of Schedule 9 to the Act; "Subsidiary" a company which is both under the Control of the Company and a subsidiary of the Company within the meaning of Section 736 of the Companies Act 1985; "Withdrawal Notice" the meaning given to that expression by Rule 4.3. 1.2 Where the context so admits 4 1.2.1 words importing the singular shall include the plural and vice versa and words importing the masculine shall include the feminine; 1.2.2 any reference to a statute (or a particular Chapter, Part or Section thereof) shall mean and include any statutory modification or re-enactment thereof for the time being in force and any regulations made thereunder. 2 OFFER AND GRANT OF OPTIONS 2.1 At such time as the Directors shall in their absolute discretion determine following the date of approval of the Plan by the Commissioners of Inland Revenue, they may give notice to each Eligible Employee on similar terms that he is invited to apply for an Option and such notice shall specify: 2.1.1 the Option Price; 2.1.2 the period, being not less than fourteen days nor more than twenty- one days from the Date of Invitation during which he may apply for an Option in accordance with Rule 2.2; 2.1.3 the Minimum Savings Contribution in respect of the offer; 2.1.4 the maximum aggregate Savings Contribution permitted under Rule 3.1; and 2.1.5 that the Option will normally be exercisable using the proceeds of a Savings Contract on the Bonus Date. 2.2 Subject to Rule 2.7, following any notice to an Eligible Employee by the Directors pursuant to Rule 2.1, he may apply for an Option by completing and returning an application in such form (not inconsistent with the provisions of the Plan) as the Directors may from time to time determine. Such form shall specify the Savings Contribution which he wishes to pay and authorise the deduction of the Savings Contribution from his remuneration. It must be accompanied by a signed form of application concerning his entry into a Savings Contract, such form to be in terms acceptable to the body administering the Contractual Savings Scheme. 2.3 Within thirty days following the Business Day referred to in the definition of Option Price in Rule 1.1 the Directors shall, in respect of each Eligible Employee who has made a valid application and who remains in the employment of any Participating Company, grant an Option stated to be over the number of Shares the aggregate of the Option Prices of which is as nearly as possible equal to, but not in excess of, the Savings Contract Repayment. No fractional shares shall be issued upon the exercise of rights granted under the Plan. 2.4 Notwithstanding any provision of any other of these Rules whatsoever: 2.4.1 the Plan shall not form part of any contract of employment between the Parent Company, the Company, a Subsidiary, a group or any Associated Company and any Participant and it shall not confer on any Participant any legal or equitable rights (other than those constituted by the Options themselves) whatsoever against the Parent Company, the Company, a Subsidiary, a group 5 or Associated Company or their officers, directors, employees, agents or assigns directly or indirectly or give rise to any cause of action at law or in equity against the Parent Company, the Company, a Subsidiary, a group or any Associated Company or their officers, directors, employees, agents or assigns; 2.4.2 the benefits to the Participants under the Plan shall not form part of their wages or remuneration or count as pay or remuneration for pension or other purposes; 2.4.3 the Grant of Options to a Participant is a matter entirely separate from any pension right or entitlement he may have and from his terms and conditions of employment and participation in the Plan shall in no respect whatever affect his pension rights or entitlements or terms or conditions of employment and in particular (but without limiting the generality of the foregoing) any Participant who ceases to be an employee of any Company in the Group or the Parent Company or any subsidiary of the Parent Company which is not a member of the Group shall not be entitled to any compensation for any loss of any right or benefit or prospective right or benefit under the Plan which he might otherwise have enjoyed whether such compensation is claimed by way of damages for wrongful dismissal or other breach of contract or by way of compensation for loss of office or otherwise howsoever and notwithstanding that he may have been dismissed wrongfully or unfairly (within the meaning of the Employment Rights Act 1996); 2.4.4 No rights granted under the Plan may be exercised to any extent unless the Plan (including rights granted thereunder) is covered by an effective registration statement pursuant to the Securities Act of 1933, as amended (the "Securities Act"). If on a Date of Exercise of any Options granted hereunder the Plan is not so registered, no rights granted under the Plan shall be exercised on said Date of Exercise and the Date of Exercise shall be delayed until the Plan is subject to such an effective registration statement, except that the Date of Exercise shall not be delayed more than two (2) months and the Date of Exercise shall in no event be later than the last date on which the Option can be exercised under Rule 4. If on the Date of Exercise of any Option granted hereunder, as delayed to the maximum extent permissible, the Plan is not registered the Option shall lapse. 2.5 An Option shall be personal to the Participant and shall not be assignable and any purported assignment, transfer, charge, disposal or dealing with the rights or interests of the Participant under the Plan shall render the Option void. However, on the death of a Participant, an Option shall be capable of being exercised by his legal personal representatives in accordance with the provisions of Rule 4. 2.6 As soon as is practicable upon the grant of an Option to a person pursuant to Rule 2.3 the Directors shall issue to the said person an Option Certificate evidencing such Option. The Option Certificate shall specify the estimated number of Shares comprised in the Option based on current exchange rates at the Date of Grant, the Date of Grant and the Option Price in respect of each such Share and shall be otherwise in such form (not inconsistent with the provisions of the Plan) as the Directors may from time to time determine. If any such certificate shall be worn out, 6 defaced, destroyed or lost, it may be renewed on such evidence being provided and on such terms as the Directors may reasonably require. 2.7 No Option shall be granted to any person (i) unless he is an employee of a Participating Company on the Date of Grant or (ii) if such person is ineligible to participate in the Plan by virtue of the provisions of paragraph 8 of Schedule 9 to the Act. 3 Individual participation limits 3.1 The aggregate of the Savings Contributions being made at any time by a Participant under the Plan (and any contributions then being made under certified contractual savings schemes linked to any other savings-related scheme or schemes approved under Schedule 9 to the Act) shall not exceed (Pounds)250 per month (or such other amount as the Directors may determine as may be permitted pursuant to paragraph 24 of Schedule 9 to the Act). 3.2 Applications made under Rule 2.2 shall be scaled down, if necessary, to ensure that the number of shares which may be issued on the exercise in full of all Options granted on any Date of Grant shall not exceed 100,000 Shares on the assumption that the prospective savings contract repayment for each Eligible Employee to whom an Option is to be granted on such Date of Grant is converted into U.S. dollars at the exchange rate prevailing on that Date of Grant. Any scaling down shall be done by the Directors who shall reduce the excess over (Pounds)10 of the monthly savings contributions chosen by each applicant on a pro rata basis and to the extent necessary. Each application under Rule 2.2 shall then be deemed to have been modified or withdrawn in accordance with the said scaling down and the Directors shall amend each application for a Savings Contract to reflect any resulting reduction in monthly savings contributions. 4 EXERCISE AND LAPSE OF OPTIONS 4.1 An Option shall be capable of being exercised in whole or in part following the earliest of :- 4.1.1 the Bonus Date if the Participant is an employee or director of a Participating Company; 4.1.2 the Bonus Date if the Participant is an employee or director of a company which is not a Participating Company but which is an Associated Company or a company of which the Company has Control; 4.1.3 the death of the Participant; 4.1.4 the Participant ceasing to be in Employment by reason of his Retirement, injury, disability or Redundancy; 7 4.1.5 the Participant ceasing to be in Employment more than three years from its Date of Grant by reason of retirement on receipt of a pension under any pension scheme of which he is a member in respect of his Employment; 4.1.6 the Participant ceasing to be in Employment by reason that his Employment is in a company of which the Company ceases to have Control, or it relates to a business or part of a business which is transferred to a person who is neither an Associated Company of the Company nor a company of which the Company has Control; 4.1.7 the Participant reaching age 60 and continuing to be in Employment in which case the right to exercise an Option under this sub- paragraph is available for a period of six months following attainment of such age provided that if he does not exercise such Option within the said period of six months he will nevertheless be able to exercise the Option on the next earliest event covered by this Rule 4.1; provided that (I) no Option shall be capable of being exercised other than at a time when the Participant is in Employment except in the circumstances described in Rules 4.1.3, 4.1.4, 4.1.5 and 4.1.6; and (II) no Option shall be capable of being exercised at a time when paragraph 8 of Schedule 9 to the Act would disqualify the Participant from being granted an Option, nor by the personal representatives of a Participant who was so precluded at the date of his death. 4.2 In no event shall an Option be capable of being exercised in respect of a number of Shares the aggregate Option Prices of which exceed the repayment made (including any bonus or interest but excluding the repayment of any contributions the due date for payment of which falls more than one month after the date on which repayment is made) to the Participant under the related Savings Contract. 4.3 An Option shall lapse to the extent that it has not been exercised by the earliest of:- 4.3.1 the expiry of six months from the Bonus Date except where the death of the Participant occurs before the expiry of such period; 4.3.2 if the Participant dies before the Bonus Date, the expiry of twelve months from the date of death of the Participant; 4.3.3 the expiry of twelve months from the Bonus Date where the death of the Participant occurs within six months after the Bonus Date; 4.3.4 the expiry of six months from the date on which the Participant ceased to be in Employment in the circumstances described in Rules 4.1.4, 4.1.5 or 4.1.6, except where the death of the Participant occurs before the expiry of such period; 8 4.3.5 the date on which the Participant ceases to be in Employment for any reason other than death or any of the circumstances referred to in Rule 4.1.4, 4.1.5 or 4.1.6; 4.3.6 the Participant's right to continue making the related Savings Contributions lapsing in respect of an Option in accordance with the provisions of the Contractual Savings Scheme before the Participant has made all the Savings Contributions required by the Contractual Savings Scheme unless such Option has already become exercisable under the provisions of this Rule; 4.3.7 the receipt by the body administering the Contractual Savings Scheme of a Withdrawal Notice in respect of the Savings Contract relative to such Option provided that such Option is not then capable of being exercised; and 4.3.8 the date on which an Option lapses pursuant to Rule 6. The Participant may direct at any time by notice (referred to as a "Withdrawal Notice") given in writing in a form acceptable to the body administering the Contractual Savings Scheme that he wishes such repayment as is then due to him to be made under the Savings Contract relative to any Option and in addition, if such notice is given in respect of the Savings Contract relative to any Option which the Participant then wishes to exercise in whole or in part, notice to that effect shall be given to the Company in such form as the Directors may prescribe (referred to as an "Exercise Notice"). 5 MANNER OF EXERCISE OF OPTIONS 5.1 In order to exercise an Option the Participant shall give to the Directors (or their nominated agent) an Exercise Notice stating that the Option is to be exercised on the Date of Exercise in respect of that number of Shares the aggregate Option Prices of which are as nearly as possible equal to, but not in excess of, the US Dollar equivalent at the Exchange Rate of the Sterling amount specified in the Exercise Notice which must be equal to or less than the repayment due under the related Savings Contract that he wishes to be applied in respect of the exercise of the Option. Such Exercise Notice shall be accompanied by payment (or an authority to obtain such payment from the body administering the Savings Contract) in full of the Sterling amount specified. It shall be the responsibility of the Participant to obtain any exchange control consents or other authorities required to enable him to exercise his Option and receive the Shares to be transferred or issued in respect thereof. 5.2 The Date of Exercise shall be the last day of the calendar month following the month in which the Directors receive the Exercise Notice, Option Certificate and Sterling proceeds of repayment under the Savings Contract specified in the Exercise Notice (provided that if such day is not a working day in the United Kingdom the next working day) or, if earlier, the last day of any period referred to in Rule 4.3 5.3 Subject to such consents or other required action of any competent authority under regulations or enactments for the time being in force as may be necessary, within thirty days after the Date of Exercise the Parent Company shall arrange for the transfer or 9 issue of the appropriate number of shares and the transferee or allottee shall be entered in the books of the Parent Company in respect of these Shares. The said Shares shall rank in full for all dividends and other rights to which a right arises by reference to a Record Date falling on or after the date on which the transferee or allottee is entered in the books of the Parent Company and shall in all other respects rank pari passu with the other Shares of the same class and shall be acquired subject to the Parent Company's By-laws. 5.4 Where an Option is exercised in part, it shall lapse to the extent of the unexercised balance. 5.5 The Parent Company shall ensure that sufficient Shares are always available to satisfy in full all outstanding Options. 6 Adjustments upon changes in shares 6.1 If any change is made in the shares, or subject to any rights granted under the Plan (through merger, consolidation, reorganisation, recapitalisation, stock dividend, dividend in property other than cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or other transaction not involving the receipt of consideration by the Parent Company), the Plan and outstanding rights will be appropriately adjusted in the class(es) and maximum number of Shares subject to the Plan and the class(es) and number of Shares and price per Share of stock subject to outstanding rights. Such adjustments shall be made by the Directors, the determination of which shall be final, binding and conclusive, subject to the Inland Revenue's consent. (The conversion of any convertible securities of the Parent Company shall not be treated as a "transaction not involving the receipt of consideration by the Parent Company"). 6.2 If any person obtains Control of the Parent Company as a result of making 6.2.1 a general offer to acquire the whole of the issued ordinary share capital of the Parent Company which is made on a condition such that if it is satisfied the person making the offer will have Control of the Parent Company; or 6.2.2 a general offer to acquire all (or substantially all) the shares in the Parent Company which are of the same class as the Shares over which Options have been granted then all outstanding Options shall lapse on the date on which such Control is obtained. 6.3 For the purposes of this Rule 6 a person shall be deemed to have obtained Control of a Company if he and others acting in concert with him have together obtained Control of it. 10 7 Amendment and administration 7.1 The Plan may be amended by resolution of the Directors provided that no amendment shall: 7.1.1 operate to disadvantage any rights already acquired by a Participant under the Plan without his consent; 7.1.2 have effect until it has been approved by the Commissioners of Inland Revenue. 7.2 Notwithstanding Rule 7.1.1 but subject to Rule 7.1.2, the Directors may by resolution amend the Plan in any way but only to the extent necessary or desirable to secure or maintain the approval of the Plan by the Commissioners of Inland Revenue under Schedule 9 to the Act. 7.3 Subject as herein otherwise expressly provided the Directors' decision on any matter concerning the Plan shall be final and binding. 7.4 The costs of the operation of the Plan shall be borne by the Company. 7.5 The Plan and Options granted under it shall be governed by and construed in accordance with English Law (except where otherwise stated) and all disputes shall be referred for resolution to the courts of England, provided that issues pertaining to or concerning the Shares and/or the Parent Company shall be governed by and construed in accordance with Delaware Law. 7.6 In any matter in which they are required to act hereunder the Auditors shall be deemed to be acting as experts and not as arbitrators and the Arbitration Acts 1950-1979 shall not apply hereto. 7.7 All notices under the Plan shall be in writing and, if to the Company, shall be either delivered in person to the Company Secretary or sent to the Company's registered office for the time being (or to such other address as the Directors may from time to time specify) and, if to a Participant, shall be delivered personally to him at his place of work or sent by first- class post to the Participant at the address which he shall give in writing to the Company for this purpose, or, failing any such address, his last known place of abode. All notices to the Company, however sent, shall be deemed to be served only upon actual receipt thereof by the Company Secretary or (as the case may be) at the appropriate address as determined above. Notices to the Participant shall, if delivered personally to him at his place of work, be deemed to be served upon such delivery and, if sent by first-class post to the appropriate address as determined above, shall be deemed to be served forty-eight hours after the posting to such address of a properly addressed and prepaid envelope containing such notice. 8 TERMINATION The Directors may at any time resolve that no further offers of participation shall be made under the Plan but in such event the subsisting rights of Participants will not thereby be affected. 11 EX-5.1 3 OPINION OF LATHAM & WATKINS EXHIBIT 5.1 [Letterhead of Latham & Watkins] March 17, 1999 Amgen Inc. One Amgen Center Drive Thousand Oaks, California 91320-1789 Re: Amgen Inc. Common Stock, par value $.0001 per share Registration on Form S-8 ---------------------------------------- Ladies and Gentlemen: At your request, we have examined the Registration Statement on Form S-8 (the "Registration Statement"), which you intend to file with the Securities and Exchange Commission in connection with the registration under the Securities Act of 1933, as amended, of an aggregate of 200,000 shares of Common Stock, par value $.0001 per share (the "Shares"), to be sold by Amgen Inc. (the "Company") under the Amgen Limited Sharesave Plan (the "Plan"). We are familiar with the proceedings undertaken in connection with the authorization and proposed issuance and sale of the Shares. Additionally, we have examined such questions of law and fact as we have considered necessary or appropriate for purposes of this opinion. Based upon the foregoing, we are of the opinion that the Shares have been duly authorized, and upon the issuance of Shares under the terms of the Plan and delivery and payment therefor of legal consideration in excess of the aggregate par value of the Shares issued, such Shares will be validly issued, fully paid and nonassessable. We consent to your filing this opinion as an exhibit to the Registration Statement. Very truly yours, /s/ Latham & Watkins EX-23.1 4 CONSENT OF ERNST & YOUNG LLP EXHIBIT 23.1 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS We consent to the incorporation by reference in the Registration Statement (Form S-8) of Amgen Inc. for the registration of 200,000 shares of Common Stock of our report dated January 26, 1999, with respect to the consolidated financial statements of Amgen Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 1998, filed with the Securities and Exchange Commission. ERNST & YOUNG LLP Los Angeles, California March 16, 1999 -----END PRIVACY-ENHANCED MESSAGE-----